Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4861782 | 1.00 | CYP2C9 (0.50) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL8734077 | 0.96 | CYP2C9 (0.47) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL8734075 | 0.96 | CYP2C9 (0.47) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL8734072 | 0.96 | CYP2C9 (0.47) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL8635813 | 0.90 | CYP2C9 (0.41) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL5244532 | 0.90 | CYP2C9 (0.41) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10931919 | 0.88 | CYP2C9 (0.50) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10927809 | 0.87 | CYP2C9 (0.49) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10927798 | 0.87 | CYP2C9 (0.49) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10933910 | 0.86 | CYP2C9 (0.48) | CYP2C9MAPTALDH1A1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1299334-B1 | CHIRAL COMPOUNDS I | MERCK PATENT GMBH (DE) | 2008-01-16 | — | — | EP | disclosed |
| US-7316830-B2 | Phenyl fluorobenzoate (p-fluorophenyl 4-(trans-4-propylcyclohexyl)-2,6-difluorobenzoate) and a bicyclohexyl compound (4,4'-vinylbicyclohexyl); very high resistivity at the same time as a broad operating temperature range, short response times, even at low temperatures, and a low threshold voltage | MERCK PATENT GMBH (DE) | 2008-01-08 | — | — | US | disclosed |
| US-7316830-B2 | Phenyl fluorobenzoate (p-fluorophenyl 4-(trans-4-propylcyclohexyl)-2,6-difluorobenzoate) and a bicyclohexyl compound (4,4'-vinylbicyclohexyl); very high resistivity at the same time as a broad operating temperature range, short response times, even at low temperatures, and a low threshold voltage | MERCK PATENT GMBH (DE) | 2008-01-08 | — | — | US | disclosed |
| US-7316830-B2 | Phenyl fluorobenzoate (p-fluorophenyl 4-(trans-4-propylcyclohexyl)-2,6-difluorobenzoate) and a bicyclohexyl compound (4,4'-vinylbicyclohexyl); very high resistivity at the same time as a broad operating temperature range, short response times, even at low temperatures, and a low threshold voltage | MERCK PATENT GMBH (DE) | 2008-01-08 | — | — | US | disclosed |
| US-7179511-B2 | For use in electro-optical displays | MERCK PATENT GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| US-7179511-B2 | For use in electro-optical displays | MERCK PATENT GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| US-7179511-B2 | For use in electro-optical displays | MERCK PATENT GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| US-20060284139-A1 | Phenyl fluorobenzoate (p-fluorophenyl 4-(trans-4-propylcyclohexyl)-2,6-difluorobenzoate) and a bicyclohexyl compound (4,4'-vinylbicyclohexyl); very high resistivity at the same time as a broad operating temperature range, short response times, even at low temperatures, and a low threshold voltage | REIFFENRATH VOLKER | 2006-12-21 | — | — | US | disclosed |
| US-20050205843-A1 | For use in electro-optical displays | REIFFENRATH VOLKER | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050205843-A1 | For use in electro-optical displays | CHRM1, EFNA1, CHRM2 | CYP2C9 2838/4885MAPT 2030/4885ALDH1A1 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.